Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 04:00PM ET
1.23
Dollar change
-0.05
Percentage change
-4.28
%
IndexRUT P/E- EPS (ttm)-0.25 Insider Own52.98% Shs Outstand773.28M Perf Week-8.89%
Market Cap857.30M Forward P/E- EPS next Y-0.26 Insider Trans3.16% Shs Float327.73M Perf Month33.80%
Income-188.89M PEG- EPS next Q-0.10 Inst Own27.27% Short Float28.56% Perf Quarter28.98%
Sales863.49M P/S0.99 EPS this Y-46.95% Inst Trans-3.05% Short Ratio9.53 Perf Half Y-13.99%
Book/sh1.80 P/B0.68 EPS next Y29.37% ROA-9.04% Short Interest93.61M Perf Year-16.33%
Cash/sh0.14 P/C8.94 EPS next 5Y12.00% ROE-12.80% 52W Range0.85 - 2.24 Perf YTD-18.54%
Dividend Est.- P/FCF- EPS past 5Y1.56% ROI-11.29% 52W High-45.09% Beta1.83
Dividend TTM- Quick Ratio1.22 Sales past 5Y3.29% Gross Margin26.88% 52W Low44.43% ATR (14)0.08
Dividend Ex-Date- Current Ratio1.55 EPS Y/Y TTM44.76% Oper. Margin-18.31% RSI (14)56.79 Volatility6.59% 7.16%
Employees3930 Debt/Eq0.24 Sales Y/Y TTM-14.02% Profit Margin-21.87% Recom1.00 Target Price4.25
Option/ShortYes / Yes LT Debt/Eq0.20 EPS Q/Q22.10% Payout- Rel Volume0.48 Prev Close1.28
Sales Surprise2.46% EPS Surprise10.00% Sales Q/Q-1.89% EarningsFeb 27 AMC Avg Volume9.82M Price1.23
SMA208.63% SMA5017.49% SMA200-14.11% Trades Volume4,736,349 Change-4.28%
Date Action Analyst Rating Change Price Target Change
Jun-29-23Upgrade Barrington Research Mkt Perform → Outperform $2
Dec-15-22Initiated H.C. Wainwright Buy $3
Jan-24-22Downgrade Barrington Research Outperform → Mkt Perform
Jun-21-21Initiated Ladenburg Thalmann Buy $7
Nov-25-19Initiated Piper Jaffray Overweight $2.50
Mar-02-18Downgrade JP Morgan Neutral → Underweight
Sep-14-17Downgrade JP Morgan Overweight → Neutral
Jun-21-16Reiterated Standpoint Research Buy $16 → $18
Jun-03-16Initiated Standpoint Research Buy $16
Mar-31-16Reiterated Barrington Research Outperform $17 → $16
Apr-01-24 01:01PM
Mar-28-24 11:08PM
08:00AM
Mar-25-24 09:57AM
Mar-20-24 08:00AM
08:52AM Loading…
Mar-05-24 08:52AM
Feb-29-24 08:31AM
Feb-28-24 09:31AM
09:02AM
06:18AM
Feb-27-24 09:00PM
07:30PM
06:10PM
05:08PM
04:43PM
04:05PM Loading…
04:05PM
Feb-26-24 09:16AM
Feb-22-24 04:05PM
Feb-08-24 01:48PM
Feb-05-24 08:09AM
Jan-22-24 11:48AM
Jan-09-24 04:05PM
Jan-08-24 08:00AM
Jan-04-24 11:31PM
Jan-03-24 05:05PM
Dec-07-23 10:20AM
Dec-06-23 11:30AM
Nov-28-23 07:00AM
Nov-07-23 10:36AM
10:29AM
09:19AM Loading…
09:19AM
06:45AM
01:00AM
Nov-06-23 07:30PM
05:30PM
05:01PM
04:05PM
Nov-02-23 10:00AM
Oct-31-23 08:00AM
Oct-25-23 04:25PM
Oct-12-23 10:50AM
Oct-06-23 12:03PM
Sep-29-23 01:03PM
Sep-28-23 07:36PM
04:08PM
Sep-13-23 01:18PM
Sep-12-23 08:30AM
Aug-28-23 11:56AM
Aug-07-23 01:21PM
Aug-04-23 01:00AM
Aug-03-23 05:55PM
04:48PM
04:05PM
Jul-25-23 04:05PM
Jul-23-23 08:11AM
Jul-12-23 08:25AM
Jun-29-23 03:51PM
11:23AM
09:53AM
08:10AM
Jun-28-23 07:03AM
06:51AM
06:45AM
Jun-08-23 07:11AM
Jun-02-23 11:31AM
May-10-23 06:13AM
May-04-23 12:23PM
05:48AM
May-03-23 10:00PM
06:25PM
05:23PM
04:05PM
Apr-25-23 04:05PM
Apr-13-23 07:46AM
Mar-17-23 06:21AM
Mar-14-23 12:08PM
Mar-09-23 03:42PM
08:00AM
Mar-08-23 04:34PM
12:01PM
08:05AM
08:01AM
08:00AM
Feb-26-23 07:13AM
06:40AM
Feb-24-23 10:43AM
07:11AM
01:00AM
Feb-23-23 04:05PM
Feb-16-23 12:17PM
11:41AM
Feb-13-23 06:03AM
Feb-09-23 07:05AM
Jan-14-23 07:26AM
Jan-03-23 08:00AM
Dec-28-22 10:06AM
Nov-29-22 10:47AM
Nov-16-22 05:08AM
Nov-09-22 08:39AM
Nov-08-22 08:30PM
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FROST PHILLIP MD ET ALCEO & ChairmanMar 18 '24Buy0.87500,000437,100210,968,225Mar 18 04:45 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 14 '24Buy0.89500,000444,300210,468,225Mar 14 05:00 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 13 '24Buy0.93500,000463,750209,968,225Mar 13 04:44 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 12 '24Buy0.93600,000559,380209,468,225Mar 12 05:27 PM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 28 '24Buy0.99500,000496,150208,868,225Feb 28 05:31 PM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 21 '24Buy0.991,000,000991,700208,368,225Feb 21 05:10 PM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 07 '24Buy0.981,500,0001,462,800207,368,225Feb 07 05:09 PM
KRASNO RICHARD MDirectorJan 29 '24Buy0.9930,00029,838103,333Jan 29 03:30 PM
FROST PHILLIP MD ET ALCEO & ChairmanJan 19 '24Buy0.98500,000488,650205,868,225Jan 19 04:54 PM
FROST PHILLIP MD ET ALCEO & ChairmanJan 18 '24Buy0.97400,000386,200205,368,225Jan 18 05:06 PM
HSIAO JANE PH DVice Chairman & CTOJan 17 '24Buy0.95150,000142,50027,999,880Jan 17 05:09 PM
FROST PHILLIP MD ET ALCEO & ChairmanJan 16 '24Buy0.951,000,000954,300204,968,225Jan 16 05:03 PM
FROST PHILLIP MD ET ALCEO & ChairmanJan 11 '24Buy0.94511,531480,379203,968,225Jan 11 05:15 PM
Nabel Gary J.Chief Innovation OfficerJan 08 '24Buy0.93216,184200,427351,442Jan 10 05:56 PM
FROST PHILLIP MD ET ALCEO & ChairmanJan 05 '24Buy0.901,500,0001,344,600203,456,694Jan 08 08:54 AM
Zerhouni Elias A.Vice Chairman and PresidentJan 05 '24Buy0.93550,300514,09320,327,814Jan 05 05:26 PM
HSIAO JANE PH DVice Chairman & CTOJan 05 '24Buy0.87150,010130,89927,849,880Jan 08 09:10 AM
PFENNIGER RICHARD C JRDirectorJan 05 '24Buy0.9425,00023,429325,000Jan 05 12:42 PM
PAGANELLI JOHN ADirectorJan 05 '24Buy0.8825,00022,080384,340Jan 05 04:00 PM
Rubin Steven DExecutive VP-AdministrationJan 05 '24Buy0.8710,0008,6696,187,732Jan 05 01:39 PM
PFENNIGER RICHARD C JRDirectorNov 13 '23Buy1.3025,00032,491300,000Nov 14 07:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 10 '23Buy1.25500,000625,462201,956,694Nov 13 08:23 AM
HSIAO JANE PH DVice Chairman & CTONov 10 '23Buy1.27100,000126,65927,699,870Nov 13 08:21 AM
Rubin Steven DExecutive VP-AdministrationNov 10 '23Buy1.3010,00013,0006,177,732Nov 13 08:21 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 09 '23Buy1.28500,000641,471201,456,694Nov 13 08:23 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 17 '23Buy1.76100,000175,804200,956,694Aug 18 07:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 14 '23Buy1.7575,000131,260200,856,694Aug 15 07:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 09 '23Buy1.82100,000181,752200,781,694Aug 10 06:59 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 07 '23Buy1.84650,0001,194,998200,681,694Aug 08 07:07 AM
Nabel Gary J.Chief Innovation OfficerMay 05 '23Buy1.84272,637500,85719,912,459May 08 07:03 AM
Nabel Gary J.Chief Innovation OfficerMay 05 '23Buy1.81187,608340,042263,079May 08 07:03 AM